236 companies

Travere Therapeutics

Market Cap: US$1.8b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

TVTX

US$20.81

7D

24.6%

1Y

246.8%

Lumentum Holdings

Market Cap: US$4.1b

Manufactures and sells optical and photonic products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.

LITE

US$58.99

7D

6.9%

1Y

35.5%

TG Therapeutics

Market Cap: US$7.0b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

TGTX

US$45.51

7D

15.2%

1Y

186.6%

Alnylam Pharmaceuticals

Market Cap: US$33.3b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

ALNY

US$263.21

7D

8.8%

1Y

75.5%

Ascendis Pharma

Market Cap: US$10.0b

A biopharmaceutical company, focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

ASND

US$170.71

7D

7.9%

1Y

21.1%

Alkami Technology

Market Cap: US$2.7b

Provides cloud-based digital banking solutions in the United States.

ALKT

US$26.71

7D

1.9%

1Y

9.5%

AVITA Medical

Market Cap: US$264.3m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

RCEL

US$9.69

7D

-0.5%

1Y

12.0%

Arcutis Biotherapeutics

Market Cap: US$1.7b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

ARQT

US$14.90

7D

3.1%

1Y

68.6%

Super Micro Computer

Market Cap: US$21.5b

Develops and sells high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally.

SMCI

US$31.86

7D

-3.2%

1Y

-56.8%

Clene

Market Cap: US$26.2m

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.

CLNN

US$2.98

7D

5.3%

1Y

-65.9%

Alvotech

Market Cap: US$2.4b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

ALVO

US$7.82

7D

-6.5%

1Y

-46.0%

Applied Optoelectronics

Market Cap: US$644.2m

Designs, manufactures, and sells fiber-optic networking products in the United States, Taiwan, and China.

AAOI

US$12.77

7D

9.5%

1Y

29.0%

Red Cat Holdings

Market Cap: US$460.7m

Provides various products, services, and solutions to the drone industry in the United States.

RCAT

US$5.02

7D

0.4%

1Y

232.5%

CoreWeave

Market Cap: US$19.9b

Operates a cloud platform that provides scaling, support, and acceleration for GenAI.

CRWV

US$41.33

7D

-0.7%

1Y

n/a

Core Scientific

Market Cap: US$2.4b

Provides digital asset mining services in the United States.

CORZ

US$8.09

7D

13.6%

1Y

169.7%

Palantir Technologies

Market Cap: US$273.9b

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.

PLTR

US$118.44

7D

17.5%

1Y

435.4%

Legend Biotech

Market Cap: US$6.3b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

LEGN

US$34.90

7D

1.7%

1Y

-20.6%

Bitdeer Technologies Group

Market Cap: US$1.9b

Operates as a technology company for blockchain and computing.

BTDR

US$9.59

7D

-2.5%

1Y

74.4%

Blueprint Medicines

Market Cap: US$5.8b

A precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.

BPMC

US$89.45

7D

4.2%

1Y

-5.7%

Similarweb

Market Cap: US$627.0m

Provides digital data and analytics for power critical business decisions in the United States, Europe, the Asia Pacific, the United Kingdom, Israel, and internationally.

SMWB

US$7.54

7D

5.6%

1Y

3.9%

SideChannel

Market Cap: US$9.6m

SideChannel, Inc. identifies, develops, and deploys of v solutions in North America.

SDCH

US$0.042

7D

-0.9%

1Y

20.0%

ARS Pharmaceuticals

Market Cap: US$1.4b

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.

SPRY

US$13.97

7D

-2.9%

1Y

49.7%

Workday

Market Cap: US$65.1b

Provides enterprise cloud applications in the United States and internationally.

WDAY

US$245.00

7D

9.0%

1Y

0.02%

Exelixis

Market Cap: US$10.6b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

EXEL

US$39.12

7D

6.4%

1Y

78.4%

TeraWulf

Market Cap: US$1.1b

Operates as a digital asset technology company in the United States.

WULF

US$2.78

7D

-0.4%

1Y

31.1%

Soleno Therapeutics

Market Cap: US$3.5b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

SLNO

US$74.86

7D

3.6%

1Y

57.5%

Zscaler

Market Cap: US$34.6b

Operates as a cloud security company worldwide.

ZS

US$226.17

7D

12.8%

1Y

31.3%

SpringWorks Therapeutics

Market Cap: US$3.5b

A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer.

SWTX

US$46.30

7D

12.4%

1Y

-1.2%

Abeona Therapeutics

Market Cap: US$257.2m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

ABEO

US$6.54

7D

25.3%

1Y

67.3%

RenovoRx

Market Cap: US$35.4m

A clinical-stage biopharmaceutical company, focuses on developing targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment.

RNXT

US$0.96

7D

-2.0%

1Y

-20.7%

Checkpoint Therapeutics

Market Cap: US$343.4m

A commercial -stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally.

CKPT

US$4.10

7D

1.5%

1Y

192.9%

Nutanix

Market Cap: US$18.3b

Provides an enterprise cloud platform in North America, Europe, the Asia Pacific, the Middle East, Latin America, and Africa.

NTNX

US$68.67

7D

8.5%

1Y

12.4%

Roadzen

Market Cap: US$64.3m

Operates as an insurance technology company.

RDZN

US$0.97

7D

11.3%

1Y

-77.2%

Duos Technologies Group

Market Cap: US$87.9m

Designs, develops, deploys, and operates intelligent technology solutions in North America.

DUOT

US$7.00

7D

14.0%

1Y

129.5%

Silence Therapeutics

Market Cap: US$160.6m

A biotechnology company, engages in the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.

SLN

US$3.70

7D

11.4%

1Y

-82.7%

Tenaya Therapeutics

Market Cap: US$78.6m

A clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.

TNYA

US$0.47

7D

5.2%

1Y

-89.9%

Page 1 of 7